Katherine E Griffin, Kathryn Snyder, Amir H Javid, Amber Hackstadt, Robert Greevy, Carlos G Grijalva, Christianne L Roumie
{"title":"对Griffin等人评论的回应使用SGLT2i与DPP-4i作为附加治疗和pad相关手术事件(截肢、支架置入或血管手术)的风险:一项糖尿病退伍军人的队列研究糖尿病护理2025;48:361-370。","authors":"Katherine E Griffin, Kathryn Snyder, Amir H Javid, Amber Hackstadt, Robert Greevy, Carlos G Grijalva, Christianne L Roumie","doi":"10.2337/dci25-0061","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":93979,"journal":{"name":"Diabetes care","volume":"48 9","pages":"e113-e114"},"PeriodicalIF":16.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368370/pdf/","citationCount":"0","resultStr":"{\"title\":\"Response to Comment on Griffin et al. Use of SGLT2i Versus DPP-4i as an Add-on Therapy and the Risk of PAD-Related Surgical Events (Amputation, Stent Placement, or Vascular Surgery): A Cohort Study in Veterans With Diabetes. Diabetes Care 2025;48:361-370.\",\"authors\":\"Katherine E Griffin, Kathryn Snyder, Amir H Javid, Amber Hackstadt, Robert Greevy, Carlos G Grijalva, Christianne L Roumie\",\"doi\":\"10.2337/dci25-0061\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":93979,\"journal\":{\"name\":\"Diabetes care\",\"volume\":\"48 9\",\"pages\":\"e113-e114\"},\"PeriodicalIF\":16.6000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368370/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2337/dci25-0061\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/dci25-0061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Response to Comment on Griffin et al. Use of SGLT2i Versus DPP-4i as an Add-on Therapy and the Risk of PAD-Related Surgical Events (Amputation, Stent Placement, or Vascular Surgery): A Cohort Study in Veterans With Diabetes. Diabetes Care 2025;48:361-370.